Eton Pharmaceuticals Inc. (ETON)
14.15
0.73 (5.44%)
At close: Jan 15, 2025, 2:24 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| PE Ratio | -120.01 | -7.25 | -36.52 | -5.92 | -7.09 | -3.08 | -15.25 |
| PS Ratio | 3.55 | 3.34 | 4.95 | 4.38K | 133.34 | n/a | n/a |
| PB Ratio | 7.26 | 5.42 | 6.13 | 10.91 | 12.12 | 1.49 | 9.00 |
| P/FCF Ratio | 18.60 | 34.88 | -13.55 | -7.63 | -6.44 | -4.69 | -22.51 |
| P/OCF Ratio | 16.48 | 14.71 | -22.91 | -7.64 | -7.09 | -4.82 | -23.13 |
| OCF/S Ratio | 0.22 | 0.23 | -0.22 | -572.97 | -18.8 | n/a | n/a |
| Debt / Equity Ratio | 0.35 | 0.50 | 0.38 | 0.46 | 0.43 | n/a | n/a |
| Quick Ratio | 1.60 | 3.01 | 5.06 | 6.18 | 7.45 | 13.59 | 16.76 |
| Current Ratio | 1.65 | 3.10 | 5.18 | 6.51 | 7.65 | 13.59 | 16.76 |
| Asset Turnover | 1.00 | 0.85 | 0.79 | 0.00 | 0.06 | n/a | n/a |
| Interest Coverage | n/a | -8.65 | -1.49 | -30.5 | n/a | n/a | n/a |
| Return on Equity (ROE) | -0.06 | -0.75 | -0.17 | -1.84 | -1.71 | -0.48 | -0.59 |
| Return on Assets (ROA) | -0.03 | -0.39 | -0.11 | -1.1 | -1.06 | -0.45 | -0.53 |
| Return on Capital (ROIC) | -0.08 | -0.44 | -0.07 | -1.2 | -1.23 | -0.39 | -0.57 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | 0.03 | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | -0.08 | n/a |
| Gross Profit Margin | 66.56% | 67.38% | 87.99% | -633.33% | 52.76% | n/a | n/a |
| Net Profit Margin | -2.96% | -46.03% | -13.56% | -73.92K% | -1.88K% | n/a | n/a |
| Pretax Profit Margin | -2.18% | -42.45% | -8.95% | -71.72K% | -1.91K% | n/a | n/a |
| Operating Profit Margin | -3.77% | -38.87% | -6.85% | -69.52K% | -1.94K% | n/a | n/a |
| FCF Margin | 19.09% | 9.57% | -36.55% | -57.43K% | -2.07K% | n/a | n/a |
| EBITDA Margin | -0.92% | -30.52% | -5.13% | -67.85K% | -1.89K% | n/a | n/a |